Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Heska Corp (HSKA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 694,200
  • Shares Outstanding, K 7,120
  • Annual Sales, $ 130,080 K
  • Annual Income, $ 10,510 K
  • 36-Month Beta 0.71
  • Price/Sales 5.39
  • Price/Cash Flow 44.90
  • Price/Book 7.53

Price Performance

See More
Period Period Low Period High Performance
1-Month
91.64 +6.39%
on 06/16/17
101.86 -4.28%
on 06/01/17
-0.56 (-0.57%)
since 05/23/17
3-Month
87.01 +12.06%
on 05/05/17
110.25 -11.56%
on 05/01/17
-0.73 (-0.74%)
since 03/23/17
52-Week
32.26 +202.23%
on 06/24/16
110.25 -11.56%
on 05/01/17
+62.95 (+182.20%)
since 06/23/16

Most Recent Stories

More News
Why Heska (HSKA) Could Be Positioned for a Surge

Heska (HSKA) is seeing positive earnings estimate revisions suggesting that it could be a solid choice for investors.

HSKA : 97.50 (-1.13%)
5 Top Efficient Stocks to Boost Your Portfolio

A company with a favorable efficiency level is expected to provide impressive returns as it is positively correlated with the price performance.

HSKA : 97.50 (-1.13%)
MXL : 29.86 (+0.98%)
LNTH : 15.60 (+3.31%)
BAX : 61.38 (+1.15%)
HD : 151.31 (-2.68%)
Exelixis (EXEL) Posts Earnings in Q1, Cabometyx in Focus

Exelixis posted earnings in the first quarter of 2017 while revenues beat estimates driven by Cabometyx.

HSKA : 97.50 (-1.13%)
EXEL : 23.78 (-1.20%)
RHHBY : 32.7600 (+1.42%)
BMY : 56.64 (-1.20%)
Radius Health (RDUS) Posts Wider Q1 Loss, Tymlos Approved

Radius Health, Inc. (RDUS) posted a wider-than-expected loss of $1.32 per share in the first quarter of 2017 which were overshadowed by the approval of Tymlos.

HSKA : 97.50 (-1.13%)
RDUS : 47.12 (+1.44%)
LLY : 83.89 (-0.50%)
AMGN : 172.50 (-0.76%)
CVS Health (CVS) Q1 Earnings Beat Estimates, Decrease Y/Y

CVS Health Corporation (CVS) reported first-quarter 2017 adjusted earnings per share (EPS) of $1.17, down 0.8% year over year.

HSKA : 97.50 (-1.13%)
CVS : 77.41 (+0.25%)
HOLX : 46.13 (-0.77%)
PGNX : 7.51 (-1.18%)
Investor Network: Heska Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 2, 2017 / Heska Corporation (NASDAQ: HSKA) will be discussing their earnings results in their Q1 Earnings Call to be held May 2, 2017 at 11:00 AM Eastern Time.

HSKA : 97.50 (-1.13%)
Heska Reports First Quarter Results

Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, today reported financial results for its first quarter ended March...

HSKA : 97.50 (-1.13%)
Hill-Rom (HRC) Beats Earnings & Revenue Estimates in Q2

Hill-Rom Holdings, Inc. (HRC) reported second-quarter fiscal 2017 adjusted earnings per share (EPS) of 88 cents, up 23.9% from the year-ago quarter.

HSKA : 97.50 (-1.13%)
HOLX : 46.13 (-0.77%)
PGNX : 7.51 (-1.18%)
HRC : 80.53 (+0.35%)
Sarepta (SRPT) Q1 Loss Narrows, Exondys 51 Sales Pick Up

Sarepta Therapeutics, Inc. (SRPT) reported narrower-than-expected loss in the first quarter of 2017. Meanwhile, the biotech company increased its 2017 sales outlook for Exondys 51 as patient and physician...

HSKA : 97.50 (-1.13%)
SRPT : 35.02 (-1.30%)
GILD : 70.52 (+0.06%)
REGN : 517.33 (-1.75%)
AstraZeneca (AZN) Q1 Earnings Beat, Revenues Meet Estimates

AstraZeneca PLC (AZN) reported first-quarter 2017 core earnings of 99 cents per American Depositary Share, which comfortably beat the Zacks Consensus Estimate of 38 cents.

HSKA : 97.50 (-1.13%)
AGLE : 3.58 (-9.37%)
GALE : 0.57 (-6.56%)
AZN : 35.07 (-0.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Heska Corporation is focused on the discovery, development and marketing ofcompanion animal health products. In addition to manufacturing certain ofcompanion animal products, the company's primary manufacturing subsidiary, Diamond Animal Health, Inc., also manufactures animal health vaccine products...

See More

Support & Resistance

2nd Resistance Point 100.29
1st Resistance Point 98.90
Last Price 97.50
1st Support Level 96.65
2nd Support Level 95.79

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.